Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intrapleural Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion, A Randomized, Multicenter Study

NCT02054078 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT02054078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02054078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intrapleural Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion, A Randomized, Multicenter Study
Lead sponsor
Tang-Du Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2012
Completion date
Not reported
Enrollment
183 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusion